ISLAND PHARMACEUTICALS LIMITED

0.00%

42.5¢

Market Cap $108.2M

Healthcare Biotechnology

Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is... Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Its lead asset is ISLA-101, a drug with a safety profile being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. While ISLA-101 is an oral formulation, the Company is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The Company operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run.

Latest Threads

Tag

Subject

ILA

Ann: Trading Halt

09:56

4.7K

09:56

Last post manlymanly

4.7K

ILA

Ann: Webinar - FDA response to Galidesivir program

09:41

4.8K

09:41

Last post cdoyle

4.8K

ILA

Ann: Change of registered address

09:23

470

09:23

Last post thechino

470

ILA

Chart

3 4 5

13/11/25

266

68K

13/11/25

Last post jarpan

266

68K

ILA

Ann: Change of Director's Interest Notice - DF, JC & CN

13/11/25

248

13/11/25

Last post

ASX News

248

ILA

Ann: Notification regarding unquoted securities - ILA

13/11/25

167

13/11/25

Last post

ASX News

167

ILA

ILA - Media coverage

2 3

11/11/25

128

42K

11/11/25

Last post arsenal1954

128

42K

ILA

Ann: FDA confirms response timing for Galidesivir

10/11/25

4.0K

10/11/25

Last post Pulpfiction

4.0K

See All Discussions

Timeline

Change of registered address
14 Nov 08:53	Share

Webinar - FDA response to Galidesivir program
13 Nov 14:34	Share

Trading Halt
13 Nov 09:12	Share

Change of Director's Interest Notice - DF, JC & CN
13 Nov 08:30	Share

Notification regarding unquoted securities - ILA
13 Nov 08:24	Share

Change of Director's Interest Notice - CN
05 Nov 09:10	Share

Change of Director's Interest Notice - DF
05 Nov 09:07	Share

Cleansing Notice
30 Oct 09:11	Share

Application for quotation of securities - ILA
30 Oct 09:09	Share

Quarterly Appendix 4C and Activities Report
30 Oct 09:02	Share

FDA confirms response timing for Galidesivir
22 Oct 09:33	Share

Cleansing Notice
17 Oct 09:13	Share

Application for quotation of securities - ILA
17 Oct 09:10	Share

Results of AGM
09 Oct 13:24	Share

Notification regarding unquoted securities - ILA
03 Oct 08:46	Share

US FDA Type C meeting briefing document submitted
29 Sep 08:29	Share

FDA Meeting request granted
19 Sep 09:29	Share

Investor webinar
18 Sep 09:06	Share

Investor presentation - Galidesivir update
17 Sep 09:53	Share

Cleansing Notice
09 Sep 08:29	Share

Application for quotation of securities - ILA
09 Sep 08:29	Share

Letter to Shareholders, Notice of AGM & Proxy Form
05 Sep 09:44	Share

FDA meeting request lodged for Galidesivir
01 Sep 08:45	Share

Annual Report to shareholders (incl auditor independence)
29 Aug 10:09	Share

Appendix 4G and Corporate Governance Statement
29 Aug 08:27	Share

Annual Report to shareholders
29 Aug 08:25	Share

Preliminary Final Report
29 Aug 08:22	Share

Change in substantial holding
15 Aug 10:07	Share

Date of AGM & Closing Date for Director Nominations
14 Aug 12:08	Share

Presentation to the Third Annual Dengue Endgame Summit
14 Aug 09:32	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 42.5¢		Change 0.000(0.00%)		Mkt cap ! $108.2M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	1250	42.0¢

Sellers (Offers)

Price($)	Vol.	No.
46.0¢	50000	1

View Market Depth

No.	Vol.	Price($)
1	1250	0.420
1	28862	0.415
1	5000	0.400
2	4051	0.390
1	2631	0.370

Price($)	Vol.	No.
0.460	50000	1
0.480	109000	3
0.485	30000	1
0.495	34400	3
0.500	138625	2

Last trade - 08.53am 14/11/2025 (20 minute delay)

ILA (ASX) Chart

Day chart unavailable

ISLAND PHARMACEUTICALS LIMITED

Latest Threads

This stock just expanded its US critical minerals footprint

Timeline

Featured News

Latest Videos

Island Pharmaceuticals (ASX:ILA) receives FDA feedback on clinical trial application

01 Feb 2023 15:53 (AEDT)

Latest Articles

Island enrols first subjects for Phase 2b clinical trial for dengue fever drug

Island Pharmaceuticals has enrolled its first four participants in a Phase 2b clinical trial to test ISLA-101 as progress rolls on.

Island Pharma's anti-dengue drug trial set to hit Phase 2b in Jan 2025 with FDA happy

Island Pharma has reported witnessing anti-dengue 'activity' in Phase 2a readout results of its ISLA-101 drug.

Island Pharmaceuticals (ASX:ILA) receives $1.96m grant to support ISLA-101 clinical development

Island Pharmaceuticals (ASX:ILA) has received a $1.96 million grant to support phase 2a human clinical trials of its ISLA-101 dengue fever treatment.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News